The agency’s own cost-benefit assessment for revoking the endangerment finding points to steep costs that may outweigh the savings.

Sections of the U.S. equities market (most stocks) have performed well, offering ongoing enticing opportunities despite the AI scare. Read more here.

Q4 2025 Earnings Call February 17, 2026 8:30 AM ESTCompany ParticipantsKendra Sweeney - Vice President of Investor Relations ...

Objective To conduct a systematic review and meta-analysis of the evidence on the effects of β-alanine supplementation on exercise capacity and performance. Design This study was designed in ...